Effects of clozapine and olanzapine on cortical thickness in childhood-onset schizophrenia

Schizophrenia Research

Volumn 116, Issue 1, 2010, Pages 44-48

  Mattai, Anand ^a   Chavez, Alex ^a   Greenstein, Deanna ^a   Clasen, Liv ^a   Bakalar, Jennifer ^a   Stidd, Reva ^a   Rapoport, Judith ^a   Gogtay, Nitin ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Childhood onset schizophrenia; Clozapine; Cortical thickness

Indexed keywords

CLOZAPINE; OLANZAPINE;

ADOLESCENT; ADULT; ARTICLE; AUTOMATION; BRAIN DEVELOPMENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL THICKNESS; DRUG EFFECT; DRUG EFFICACY; EXPLORATORY RESEARCH; FEMALE; GRAY MATTER; HUMAN; IMAGE ANALYSIS; MALE; NERVOUS SYSTEM PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BRAIN MAPPING; CEREBRAL CORTEX; CLOZAPINE; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA, CHILDHOOD; SEVERITY OF ILLNESS INDEX;

EID: 71549142556     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.10.018     Document Type: Article

References (47)

1. Arango C., Moreno C., Martinez S., Parellada M., Desco M., Moreno D., Fraguas D., Gogtay N., James A., and Rapoport J. Longitudinal brain changes in early-onset psychosis. Schizophr. Bull. 34 (2008) 341-353
2. Castellanos F.X., Giedd J.N., Berquin P.C., Walter J.M., Sharp W., Tran T., Vaituzis A.C., Blumenthal J.D., Nelson J., Bastain T.M., Zijdenbos A., Evans A.C., and Rapoport J.L. Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 58 (2001) 289-295
3. Chakos M.H., Lieberman J.A., Bilder R.M., Borenstein M., Lerner G., Bogerts B., Wu H., Kinon B., and Ashtari M. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am. J. Psychiatry 151 (1994) 1430-1436
4. Corson P.W., Nopoulos P., Miller D.D., Arndt S., and Andreasen N.C. Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. Am. J. Psychiatry 156 (1999) 1200-1204
5. Dazzan P., Morgan K.D., Orr K., Hutchinson G., Chitnis X., Suckling J., Fearon P., Mcguire P.K., Mallett R.M., Jones P.B., Leff J., and Murray R.M. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology 30 (2005) 765-774
6. Delisi L.E., Sakuma M., Maurizio A.M., Relja M., and Hoff A.L. Cerebral ventricular change over the first 10 years after the onset of schizophrenia. Psychiatry Res. 130 (2004) 57-70
7. Delisi L.E., Szulc K.U., Bertisch H.C., Majcher M., and Brown K. Understanding structural brain changes in schizophrenia. Dialogues Clin Neurosci 8 (2006) 71-78
8. Dorph-Petersen K.A., Pierri J.N., Perel J.M., Sun Z., Sampson A.R., and Lewis D.A. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 30 (2005) 1649-1661
9. Garver D.L., Holcomb J.A., and Christensen J.D. Cerebral cortical gray expansion associated with two second-generation antipsychotics. Biol. Psychiatry 58 (2005) 62-66
10. Genovese C.R., Lazar N.A., and Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 15 (2002) 870-878
11. Giedd J.N., Jeffries N.O., Blumenthal J., Castellanos F.X., Vaituzis A.C., Fernandez T., Hamburger S.D., Liu H., Nelson J., Bedwell J., Tran L., Lenane M., Nicolson R., and Rapoport J.L. Childhood-onset schizophrenia: progressive brain changes during adolescence. Biol. Psychiatry 46 (1999) 892-898
12. Gogtay N. Cortical brain development in schizophrenia: insights from neuroimaging studies in childhood-onset schizophrenia. Schizophr. Bull. 34 (2008) 30-36
13. Gogtay N., Greenstein D., Lenane M., Clasen L., Sharp W., Gochman P., Butler P., Evans A., and Rapoport J. Cortical brain development in nonpsychotic siblings of patients with childhood-onset schizophrenia. Arch. Gen. Psychiatry 64 (2007) 772-780
14. Gogtay N., Ordonez A., Herman D.H., Hayashi K.M., Greenstein D., Vaituzis C., Lenane M., Clasen L., Sharp W., Giedd J.N., Jung D., Nugent III T.F., Toga A.W., Leibenluft E., Thompson P.M., and Rapoport J.L. Dynamic mapping of cortical development before and after the onset of pediatric bipolar illness. J. Child Psychol. Psychiatry 48 (2007) 852-862
15. Gogtay N., and Rapoport J. Clozapine use in children and adolescents. Expert Opin. Pharmacother. 9 (2008) 459-465
16. Gogtay N., Sporn A., Clasen L.S., Nugent III T.F., Greenstein D., Nicolson R., Giedd J.N., Lenane M., Gochman P., Evans A., and Rapoport J.L. Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses. Arch. Gen. Psychiatry 61 (2004) 17-22
17. Goldman A.L., Pezawas L., Mattay V.S., Fischl B., Verchinski B.A., Chen Q., Weinberger D.R., and Meyer-Lindenberg A. Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability. Arch. Gen. Psychiatry 66 (2009) 467-477
18. Greenstein D., Lerch J., Shaw P., Clasen L., Giedd J., Gochman P., Rapoport J., and Gogtay N. Childhood onset schizophrenia: cortical brain abnormalities as young adults. J. Child Psychol. Psychiatry 47 (2006) 1003-1012
19. Greenstein D.K., Wolfe S., Gochman P., Rapoport J.L., and Gogtay N. Remission status and cortical thickness in childhood-onset schizophrenia. J. Am. Acad. Child Adolesc. Psych. (2008) 47 (10), 1133-1140
20. Gur R.E., Maany V., Mozley P.D., Swanson C., Bilker W., and Gur R.C. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am. J. Psychiatry 155 (1998) 1711-1717
21. Hazlett E.A., Buchsbaum M.S., Haznedar M.M., Newmark R., Goldstein K.E., Zelmanova Y., Glanton C.F., Torosjan Y., New A.S., Lo J.N., Mitropoulou V., and Siever L.J. Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients. Schizophr. Res. 101 (2008) 111-123
22. Ho B.C., Andreasen N.C., Nopoulos P., Arndt S., Magnotta V., and Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch. Gen. Psychiatry 60 (2003) 585-594
23. Jacobsen L.K., Giedd J.N., Castellanos F.X., Vaituzis A.C., Hamburger S.D., Kumra S., Lenane M.C., and Rapoport J.L. Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. Am. J. Psychiatry 155 (1998) 678-685
24. Kane J., Honigfeld G., Singer J., and Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch. gen. psychiatry 45 (1988) 789-796
25. Kane J., Honigfeld G., Singer J., and Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch. gen. psychiatry 45 (1988) 789-796
26. Kane J.M. Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview. Br. J. Psychiatr., Suppl. (1992) 41-45
27. Keshavan M.S., Bagwell W.W., Haas G.L., Sweeney J.A., Schooler N.R., and Pettegrew J.W. Changes in caudate volume with neuroleptic treatment. Lancet 344 (1994) 1434
28. Khorram B., Lang D.J., Kopala L.C., Vandorpe R.A., Rui Q., Goghari V.M., Smith G.N., and Honer W.G. Reduced thalamic volume in patients with chronic schizophrenia after switching from typical antipsychotic medications to olanzapine. Am. J. Psychiatry 163 (2006) 2005-2007
29. Kim J.S., Singh V., Lee J.K., Lerch J., Ad-Dab'bagh Y., Macdonald D., Lee J.M., Kim S.I., and Evans A.C. Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification. Neuroimage 27 (2005) 210-221
30. Lerch J.P., and Evans A.C. Cortical thickness analysis examined through power analysis and a population simulation. Neuroimage 24 (2005) 163-173
31. Lieberman J.A., Stroup T.S., Mcevoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Keefe R.S., Davis S.M., Davis C.E., Lebowitz B.D., Severe J., and Hsiao J.K. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 353 (2005) 1209-1223
32. Lieberman J.A., Tollefson G.D., Charles C., Zipursky R., Sharma T., Kahn R.S., Keefe R.S., Green A.I., Gur R.E., Mcevoy J., Perkins D., Hamer R.M., Gu H., and Tohen M. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch. Gen. Psychiatry 62 (2005) 361-370
33. Macdonald D., Kabani N., Avis D., and Evans A.C. Automated 3-D extraction of inner and outer surfaces of cerebral cortex from MRI. Neuroimage 12 (2000) 340-356
34. Mcevoy J.P., Lieberman J.A., Stroup T.S., Davis S.M., Meltzer H.Y., Rosenheck R.A., Swartz M.S., Perkins D.O., Keefe R.S., Davis C.E., Severe J., and Hsiao J.K. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am. J. Psychiatry 163 (2006) 600-610
35. McKenna, K., Gordon, C.T., Rapoport, J.L., 1994. Childhood-onset schizophrenia: timely neurobiological research. J. Am. Acad. Child Adolesc. Psychiatry 33, 771-781.
36. Molina V., Reig S., Sanz J., Palomo T., Benito C., Sanchez J., Sarramea F., Pascau J., and Desco M. Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia. Schizophr. Res. 80 (2005) 61-71
37. Moreno D., Burdalo M., Reig S., Parellada M., Zabala A., Desco M., Baca-Baldomero E., and Arango C. Structural neuroimaging in adolescents with a first psychotic episode. J. Am. Acad. Child Adolesc. Psych. 44 (2005) 1151-1157
38. Pantelis C., Velakoulis D., Mcgorry P.D., Wood S.J., Suckling J., Phillips L.J., Yung A.R., Bullmore E.T., Brewer W., Soulsby B., Desmond P., and Mcguire P.K. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361 (2003) 281-288
39. Rapoport J.L., Giedd J.N., Blumenthal J., Hamburger S., Jeffries N., Fernandez T., Nicolson R., Bedwell J., Lenane M., Zijdenbos A., Paus T., and Evans A. Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry 56 (1999) 649-654
40. Reig S., Moreno C., Moreno D., Burdalo M., Janssen J., Parellada M., Zabala A., Desco M., and Arango C. Progression of brain volume changes in adolescent-onset psychosis. Schizophr. Bull. 35 (2009) 233-243
41. Scherk H., and Falkai P. Effects of antipsychotics on brain structure. Curr. Opin. Psychiatry 19 (2006) 145-150
42. Shaw P., Sporn A., Gogtay N., Overman G.P., Greenstein D., Gochman P., Tossell J.W., Lenane M., and Rapoport J.L. Childhood-onset schizophrenia: a double-blind, randomized clozapine-olanzapine comparison. Arch. Gen. Psychiatry 63 (2006) 721-730
43. Sled J.G., Zijdenbos A.P., and Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imag. 17 (1998) 87-97
44. Thompson P.M., Bartzokis G., Hayashi K.M., Klunder A.D., Lu P.H., Edwards N., Hong M.S., Yu M., Geaga J.A., Toga A.W., Charles C., Perkins D.O., Mcevoy J., Hamer R.M., Tohen M., Tollefson G.D., and Lieberman J.A. Time-lapse mapping of cortical changes in schizophrenia with different treatments. Cereb. Cortex 19 (2009) 1107-1123
45. Thompson P.M., Vidal C., Giedd J.N., Gochman P., Blumenthal J., Nicolson R., Toga A.W., and Rapoport J.L. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 11650-11655
46. Van Haren N.E., Hulshoff Pol H.E., Schnack H.G., Cahn W., Brans R., Carati I., Rais M., and Kahn R.S. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol. Psychiatry 63 (2008) 106-113
47. Zijdenbos A.P., Forghani R., and Evans A.C. Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis. IEEE Trans. Med. Imag. 21 (2002) 1280-1291